Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Option Care Health, Inc. (OPCH) SEC filings page brings together the company’s official regulatory disclosures, as filed with the U.S. Securities and Exchange Commission. These documents provide detailed insight into how the nation’s largest independent provider of home and alternate site infusion services reports its financial condition, capital structure, governance changes and material agreements.
Investors can use this page to access current and historical 10-K and 10-Q reports, which contain audited and interim financial statements, segment information, risk factor discussions and management’s analysis of the business. For Option Care Health, these filings complement its earnings press releases that discuss net revenue, net income, earnings per share and non-GAAP measures such as Adjusted EBITDA, Adjusted net income and Adjusted diluted EPS, and they provide the underlying GAAP detail and reconciliations referenced in those releases.
The page also tracks Form 8-K filings, which Option Care Health uses to report material events. Recent examples include 8-Ks furnishing quarterly earnings press releases under Item 2.02, an 8-K describing a Fourth Amendment to the company’s Amended and Restated First Lien Credit Agreement under Item 1.01 and Item 2.03, and an 8-K outlining a Chief Financial Officer transition and related compensatory arrangements under Item 5.02. These filings explain changes to term loans and revolving credit facilities, leadership appointments and transitions, and other significant corporate actions.
Users interested in executive and director information can review proxy materials and governance-related filings, which describe board composition, executive compensation structures and incentive plans referenced in 8-K disclosures. For those monitoring potential insider activity, Form 4 and related ownership reports, when filed, show transactions by directors, officers and significant shareholders in OPCH stock.
To make this information more accessible, this page pairs real-time updates from the SEC’s EDGAR system with AI-powered summaries that highlight key points from lengthy filings. Instead of reading an entire credit agreement amendment or multi-hundred-page annual report, users can quickly see what changed in Option Care Health’s debt terms, how non-GAAP metrics reconcile to GAAP results, or what new risks and governance details have been disclosed, and then drill into the full documents as needed.
Option Care Health reported proposed sales of Common Stock on a Form 144. The filing lists multiple sale entries, including 750 shares on 08/20/2025 and 2,967 shares on 05/20/2025, with other award-related share amounts shown for dates in 2022–2025.
Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported two tax-related share dispositions tied to equity compensation. On February 22, he disposed of 12,212 common shares at $35.69 per share to satisfy tax obligations. On February 20, he similarly disposed of 1,187 shares at $35.69 per share for tax withholding. These transactions are coded as tax-withholding events rather than open-market sales, and he continues to hold a meaningful number of shares directly.
Option Care Health, Inc. Chief Growth Officer Christopher L. Grashoff reported two tax-related share dispositions of company common stock. On February 20, 1,948 shares were disposed of at
Option Care Health, Inc. Chief Accounting Officer Nicole Maggio reported two tax-related share dispositions under a compensation plan. On February 20 and 22, she transferred a total of 991 shares of common stock at $35.69 per share to satisfy tax withholding obligations, a non-open-market transaction type coded as "F." After these transactions, she directly owned 29,464 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Operating Officer Luke Whitworth reported two tax-related share dispositions under an equity compensation arrangement. On February 22, 2026, 24,029 shares of common stock were delivered at
Option Care Health CEO John Charles Rademacher reported a mix of share acquisitions and tax-related dispositions. On February 21, 2026, he exercised 11,087 Restricted Stock Units, each converting into one share of common stock at a stated price of
To cover tax obligations, he reported multiple F-code tax-withholding dispositions of common stock on February 20–22, 2026 at
Option Care Health, Inc. reported insider transactions by its General Counsel and Corporate Secretary, Collin Smyser. On February 22, 2026, Smyser disposed of 15,433 shares of common stock at
Option Care Health, Inc. is the largest independent U.S. provider of home and alternate-site infusion services, operating 196 locations in 43 states and a team of more than 5,000 clinicians. It runs 87 full-service pharmacies and 109 stand‑alone ambulatory infusion suites to treat complex and chronic conditions ranging from infections to neurological and inflammatory disorders.
The business is highly dependent on third‑party payers; for 2025, 88% of revenue came from managed care and other nongovernmental payers and 12% from direct government programs like Medicare and Medicaid. Its largest payer contributed 14% of revenue, and about 68% of drug and supply purchases came from four vendors, creating concentration risk.
The company discloses $1,176.3 million of debt as of December 31, 2025, split between a $676.3 million first‑lien term loan and $500.0 million of 4.375% senior notes due 2029. It notes federal reimbursement pressure, including Medicare sequestration and a CMS‑negotiated 66% price cut effective January 2026 for one portfolio therapy under the Inflation Reduction Act, as potential headwinds. As of June 30, 2025, non‑affiliate equity value was about $5.27 billion, with 156,447,972 common shares outstanding as of February 19, 2026, and a share repurchase authorization increased to $1 billion in January 2026.
Option Care Health reported solid fourth quarter and full-year 2025 results with continued growth and significant shareholder returns. Fourth quarter net revenue reached $1,465.4 million, up 8.8%, while net income was $58.5 million, down 2.7%. GAAP diluted EPS rose 5.7% to $0.37, and Adjusted EBITDA increased 3.7% to $126.0 million. The company repurchased $95 million of stock in the quarter.
For full year 2025, net revenue grew 13.0% to $5,649.5 million, with net income of $207.6 million, down 2.0%. GAAP diluted EPS increased 3.3% to $1.27, and Adjusted EBITDA rose 6.2% to $471.3 million. Adjusted diluted EPS was $1.72, up 8.9%, and operating cash flow was $258.4 million. The company repurchased $307 million of stock during the year.
Looking to 2026, Option Care Health expects net revenue of $5.8 billion to $6.0 billion, Adjusted EBITDA of $480 million to $505 million, Adjusted diluted EPS of $1.82 to $1.92, and operating cash flow of at least $340 million, signaling confidence in continued growth.
Option Care Health Chief Operating Officer Luke Whitworth reported two equity-related transactions in company common stock. He received a grant of 30,423 restricted stock units at no cost, which vest in three equal annual installments. Separately, 508 shares were disposed of to cover tax withholding obligations tied to equity compensation.